Inventor · disambiguated record
Srinivasa Reddy Natala
Also filed as: NATALA SRINIVASA REDDY
13 granted patents·8 pending applications·23 citations·filing 2004–2023
89Inventor score
Files withNEUROPORE THERAPIES INC10NOVARTIS AG5TAKEDA PHARMACEUTICAL2CALASIA PHARMACEUTICALS INC1CHOI HA-SOON1
Top patents by PatentIndex Score
21 records- 0192US10660881B2Compounds and compositions for inducing chondrogenesisNOVARTIS AG·Filed 2019·Granted May 26, 2020·3 cites·20 claims
- 0291US11510912B2Compounds and compositions for inducing chondrogenesisNOVARTIS AG·Filed 2020·Granted Nov 29, 2022·2 cites·16 claims
- 0389US11008294B2Substituted phenyl sulfonyl phenyl triazole thiones and uses thereofNEUROPORE THERAPIES INC·Filed 2019·Granted May 18, 2021·3 cites·22 claims
- 0487US10501423B2Substituted phenyl sulfonyl phenyl triazole thiones and uses thereofNEUROPORE THERAPIES INC·Filed 2019·Granted Dec 10, 2019·3 cites·23 claims
- 0586US11708338B2Substituted phenyl sulfonyl phenyl triazole thiones and uses thereofNEUROPORE THERAPIES INC·Filed 2021·Granted Jul 25, 2023·1 cites·24 claims
- 0686US10188638B2Compounds and compositions for inducing chondrogenesisNOVARTIS AG·Filed 2017·Granted Jan 29, 2019·4 cites·23 claims
- 0784US12280041B2Compounds and compositions for inducing chondrogenesisNOVARTIS AG·Filed 2022·Granted Apr 22, 2025·0 cites·20 claims
- 0882US10383863B2Compounds and compositions for inducing chondrogenesisNOVARTIS AG·Filed 2018·Granted Aug 20, 2019·2 cites·25 claims
- 0980US9688689B2Compounds and compositions for inducing chondrogenesisCHOI HA-SOON·Filed 2015·Granted Jun 27, 2017·4 cites·28 claims
- 1079US2023391734A1Substituted phenyl sulfonyl phenyl triazole thiones and uses thereofNEUROPORE THERAPIES INC·Filed 2023·Application pending·0 cites
- 1173US2022396583A1Compounds as modulators of tlr2 signalingNEUROPORE THERAPIES INC·Filed 2022·Application pending·0 cites
- 1272US2022298155A1Compounds and compositions as modulators of tlr signalingNEUROPORE THERAPIES INC·Filed 2022·Application pending·0 cites
- 1368US11345713B2Compounds as modulators of TLR2 signalingNEUROPORE THERAPIES INC·Filed 2019·Granted May 31, 2022·0 cites·16 claims
- 1461US11299487B2Compounds and compositions as modulators of TLR signalingNEUROPORE THERAPIES INC·Filed 2020·Granted Apr 12, 2022·0 cites·8 claims
- 1557US6852754B1Biologically active linderazulene terpenesHARBOR BRANCH OCEANOGRAPHIC·Filed 2004·Granted Feb 8, 2005·1 cites·21 claims
- 1656US2024043395A1Compounds and compositions as modulators of tlr signalingNEUROPORE THERAPIES INC·Filed 2021·Application pending·0 cites
- 1752US2010075973A1Polo-like kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 1850US2009291938A1Polo-like kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 1949US2017327497A1Substituted 6-aza-isoindolin-1-one derivativesTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 2041US2021290597A1Method of treating a condition associated with neurodegeneration using inhibitors of oat3NEUROPORE THERAPIES INC·Filed 2019·Application pending·0 cites
- 2131US10189824B2Pyrimidine-diamine dual HSP90/TRAP1 inhibitorsCALASIA PHARMACEUTICALS INC·Filed 2015·Granted Jan 29, 2019·0 cites·27 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →